Table 1 Demographic, clinical and laboratory data of patients with systemic sclerosis and healthy controls
Systemic sclerosis patients (n= 44) | Healthy controls (n= 40) | P value | |
|---|---|---|---|
Age (years) | 47.4 ± 10.5 | 46.9 ± 8.1 | 0.807 |
Gender (female/male) | 41/3 | 37/3 | 0.904 |
Duration of Raynaud's phenomenon (years) | 8.0 ± 7.1 | - | - |
Disease duration (years) | 5.9 ± 5.5 | - | - |
Presence of digital pitting scars, fingertip resorption, or digit amputation | 25 (56.8%) | - | - |
Antinuclear antibody | 37 (84.1%) | - | - |
Anti-Scl70 antibody | 3 (6.8%) | - | - |
Anti-centromere antibody | 13 (29.5%) | - | - |
Number of patients using calcium channel blockers (%) | 20 (45%) | - | - |